Treatment of blast phase chronic myeloid leukaemia: A rare and challenging entity-Reference-Cited by-同舟云学术

Treatment of blast phase chronic myeloid leukaemia: A rare and challenging entity

Published:2022-07-22 Issue:5 Volume:199 Page:665-678
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Copland Mhairi¹^ORCID

Affiliation:

1. Paul O'Gorman Leukaemia Research Centre, College of Medical, Veterinary & Life Sciences Institute of Cancer Sciences, University of Glasgow Glasgow UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18370

Reference102 articles.

1. Epidemiology of chronic myeloid leukaemia: an update

2. Structural organization of the bcr gene and its role in the Ph′ translocation

3. Treatment and outcome of 2904 CML patients from the EUTOS population-based registry

4. Management of Advanced-Phase Chronic Myeloid Leukemia

5. How I treat CML blast crisis

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigations on druggable gene mutations related to AML/ALL lineage genes in Advanced Phases of CML: Implications in patient-tailored therapy of blast crisis CML in TKI era;2024-09-09

2. Chronic myeloid leukaemia: Biology and therapy;Blood Reviews;2024-05

3. Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations;Leukemia;2024-04-13

4. A comprehensive review on role of Aurora kinase inhibitors (AKIs) in cancer therapeutics;International Journal of Biological Macromolecules;2024-04

5. Destructive cervical spine disease with concomitant chronic myeloid leukemia: A case report;Cancer Research, Statistics, and Treatment;2024-04